# Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks

> clinical trial · VERIFIED · 2026-06-30

Status: RECRUITING · Sponsor: Octapharma · Condition: Acute Hereditary Angio Edema

- Company: Octapharma
- Sector: pharma
- Primary source: https://clinicaltrials.gov/study/NCT06361537

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.